Related Articles
The AP-1/NF-κB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia
Formoterol treatment down-regulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats
Calpain inhibitors ameliorate muscle wasting in a cachectic mouse model bearing CT26 colorectal adenocarcinoma
Effects of the PPARγ agonist GW1929 on muscle wasting in tumour-bearing mice
β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy